Kebede H. Begna

Also affiliated with Mayo Clinic in Arizona, St. Paul's Hospital Millennium Medical College

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients”.

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

American Journal of Hematology(2024)10.1002/ajh.27138

N/A

0.654DataRank · unranked

77 citations

Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M. Johnson, Maymona Abdelmagid +21 more

Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases

American Journal of Hematology(2021)10.1002/ajh.26186

N/A

0.631DataRank · unranked

66 citations

Paola Guglielmelli, Natasha Szuber, Kebede H. Begna, Mrinal M. Patnaik, Mark R. Litzow +11 more

Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm

Haematologica(2022)10.3324/haematol.2022.282019

N/A

0.449DataRank · unranked

19 citations

Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M. Patnaik +13 more

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Blood Advances(2024)10.1182/bloodadvances.2024014633

N/A

0.420DataRank · unranked

9 citations

Danielle M. Brander, Yesid Alvarado, Catherine Diefenbach, Daniel Nathan Egan, Shira Dinner +14 more

Mast cell cytomorphology and treatment outcome in mast cell leukemia

American Journal of Hematology(2024)10.1002/ajh.27105

N/A

0.241DataRank · unranked

4 citations

Animesh Pardanani, Aref Al‐Kali, Hassan Alkhateeb, Kristen McCullough, Mrinal M. Patnaik +11 more

The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia

Blood Neoplasia(2025)10.1016/j.bneo.2025.100108

N/A

0.173DataRank · unranked

2 citations

Rachel J. Cook, Shira Dinner, Michael Keng, Kebede H. Begna, Nathalie Javidi‐Sharifi +9 more

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia

Blood Cancer Journal(2020)10.1038/s41408-020-00387-y

N/A

0DataRank · unranked

37 citations

Aasiya Matin, Abhishek A. Mangaonkar, Ryan M. Carr, Moritz Binder, Aref Al‐Kali +9 more

Spectrum of clonal hematopoiesis in VEXAS syndrome

Blood(2023)10.1182/blood.2022018774

N/A

0DataRank · unranked

104 citations

Yael Kusne, Jenna Fernandez, Terra L. Lasho, Ruba Shalhoub, Xiaoyang Ma +31 more

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

Haematologica(2022)10.3324/haematol.2021.280463

N/A

0DataRank · unranked

8 citations

Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough +16 more

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

Blood Cancer Journal(2022)10.1038/s41408-022-00622-8

N/A

0DataRank · unranked

20 citations

Terra L. Lasho, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat, Aref Al‐Kali +10 more

Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia

American Journal of Hematology(2020)10.1002/ajh.25729

N/A

0DataRank · unranked

6 citations

Ryan A. Knudson, Kathryn E. Pearce, Reid G. Meyer, Beth A. Pitel, Jess F. Peterson +23 more